BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wishahi M. Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors. World J Clin Cases 2024; 12(13): 2143-2146 [PMID: 38808339 DOI: 10.12998/wjcc.v12.i13.2143]
URL: https://www.wjgnet.com/2307-8960/full/v12/i13/2143.htm
Number Citing Articles
1
G. A. Kovchenko, A. V. Sivkov, L. N. Lyubchenko, A. D. Kaprin. Epigenetic abnormalities and neuroendocrine differentiation in prostate cancerSiberian journal of oncology 2025; 24(1): 115 doi: 10.21294/1814-4861-2025-24-1-115-124